TEE and Dysphagia in Lung Transplantation
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Oct 12, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how reducing the number of pictures taken during a special heart imaging procedure, called transesophageal echocardiography (TEE), might help patients who have difficulty swallowing (known as dysphagia) after receiving a lung transplant. At UCLA, TEE is a standard part of the lung transplant process, and this study aims to see if taking fewer images during the procedure can lead to better swallowing outcomes for patients.
To be eligible for this trial, participants need to be adults who are undergoing either a single or double lung transplant. However, those with certain medical conditions that make TEE unsafe, such as a perforated esophagus or those needing a tracheostomy after surgery, cannot participate. If you join the study, you will be placed in one of two groups: one group will have fewer TEE images taken, while the other group will have the usual number taken. Researchers hope this approach will improve swallowing function after the transplant.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Adult patients
- • 2. Single or double lung transplantation
- Exclusion Criteria:
- 1. Contraindications to TEE including:
- • perforated esophagus;
- • esophageal stricture;
- • esophageal tumor; and
- • history of an esophagectomy
- • 2. Patients that require a tracheostomy postoperatively.
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
J.Prince Neelankavil, MD
Principal Investigator
University of California, Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported